Cargando…

EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update

We have previously described the role played by toxic-metal burdens in the etiology of neurodegenerative diseases (ND). We herein report an updated evaluation of toxic-metal burdens in human subjects affected or not affected by ND or other chronic diseases. Each subject underwent a chelation test wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulgenzi, Alessandro, Vietti, Daniele, Ferrero, Maria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460255/
https://www.ncbi.nlm.nih.gov/pubmed/32756375
http://dx.doi.org/10.3390/biomedicines8080269
_version_ 1783576560095199232
author Fulgenzi, Alessandro
Vietti, Daniele
Ferrero, Maria Elena
author_facet Fulgenzi, Alessandro
Vietti, Daniele
Ferrero, Maria Elena
author_sort Fulgenzi, Alessandro
collection PubMed
description We have previously described the role played by toxic-metal burdens in the etiology of neurodegenerative diseases (ND). We herein report an updated evaluation of toxic-metal burdens in human subjects affected or not affected by ND or other chronic diseases. Each subject underwent a chelation test with the chelating agent calcium disodium ethylenediaminetetraacetic acid (CaNA(2)EDTA or EDTA) to identify the presence of 20 toxic metals in urine samples using inductively coupled plasma mass spectrometry. Our results show the constant presence of toxic metals, such as lead, cadmium, cesium, and aluminum, in all examined subjects but the absence of beryllium and tellurium. Gadolinium was detected in patients undergoing diagnostic magnetic resonance imaging. The presence of toxic metals was always significantly more elevated in ND patients than in healthy controls. Treatment with EDTA chelation therapy removes toxic-metal burdens and improves patient symptoms.
format Online
Article
Text
id pubmed-7460255
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74602552020-09-02 EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update Fulgenzi, Alessandro Vietti, Daniele Ferrero, Maria Elena Biomedicines Article We have previously described the role played by toxic-metal burdens in the etiology of neurodegenerative diseases (ND). We herein report an updated evaluation of toxic-metal burdens in human subjects affected or not affected by ND or other chronic diseases. Each subject underwent a chelation test with the chelating agent calcium disodium ethylenediaminetetraacetic acid (CaNA(2)EDTA or EDTA) to identify the presence of 20 toxic metals in urine samples using inductively coupled plasma mass spectrometry. Our results show the constant presence of toxic metals, such as lead, cadmium, cesium, and aluminum, in all examined subjects but the absence of beryllium and tellurium. Gadolinium was detected in patients undergoing diagnostic magnetic resonance imaging. The presence of toxic metals was always significantly more elevated in ND patients than in healthy controls. Treatment with EDTA chelation therapy removes toxic-metal burdens and improves patient symptoms. MDPI 2020-08-03 /pmc/articles/PMC7460255/ /pubmed/32756375 http://dx.doi.org/10.3390/biomedicines8080269 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fulgenzi, Alessandro
Vietti, Daniele
Ferrero, Maria Elena
EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_full EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_fullStr EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_full_unstemmed EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_short EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
title_sort edta chelation therapy in the treatment of neurodegenerative diseases: an update
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460255/
https://www.ncbi.nlm.nih.gov/pubmed/32756375
http://dx.doi.org/10.3390/biomedicines8080269
work_keys_str_mv AT fulgenzialessandro edtachelationtherapyinthetreatmentofneurodegenerativediseasesanupdate
AT viettidaniele edtachelationtherapyinthetreatmentofneurodegenerativediseasesanupdate
AT ferreromariaelena edtachelationtherapyinthetreatmentofneurodegenerativediseasesanupdate